Skin - commissioning policies
Please click on the links below to access the commissioning policies. The associated Equality Impact Assessments, if currently available, are accessible here.Benign skin and subcutaneous lesions - assessment and removalClick here to download this file
The CCGs’ position on the implementation of policies affecting patient referral can be found here.
Add this document to cart
To access the accompanying Clinical policy patient support information for the benign skin lesions policy please click here.Brimonidine gel (Mirvaso®) for the symptomatic treatment of facial erythema of rosacea in adult patientsClick here to download this file
Add this document to cartClindamycin 1%/Tretinoin 0.025% gel (Treclin®) for the topical treatment of acne vulgarisClick here to download this file
Add this document to cartFocal hyperhidrosisClick here to download this file
Add this document to cartImiquimod 3.75% (Zyclara™) for actinic keratosisClick here to download this file
Add this document to cartIvermectin 1% cream (Soolantra®) for the treatment of inflammatory lesions of papulopustular rosaceaClick here to download this file
Add this document to cartSurgery for ganglion cyst (see surgery commissioning policies, click here)
Please note: Some commissioning policies approved by the previous commissioning organisations are yet to be reviewed and updated. There is an on-going programme of work in place to review and update these policies. They will then be published under the appropriate category.
In the meantime they are still applicable to Northern, Eastern and Western Devon CCG. Former NHS Devon policies can be accessed here.